The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies

Sriramkumar Sundaramoorthy · Chandra Bindu Yerram · Ritu Mehdiratta · Gayatri Saberwal

5 citations0/0 files storedSSRN Electronic Journal

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Intellectual Property and Patents Pharmaceutical Economics and Policy Biotechnology and Related Fields

Abstract

We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It will serve as a baseline for the scenario in future.(Article freely downloadable from the journal website.)

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Imported from OpenAlex (CC0) — nothing here is generated.